ImmunityBio, Inc. (IBRX)

NASDAQ

$8.50

$-0.23

(-2.62%)

Regular Market

ImmunityBio, Inc. (IBRX) Live Price Chart

Last updated: ⁦2026-10-21 15:03:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

ImmunityBio, Inc. (IBRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $8.50, with a market capitalization of $8.92B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.95 to $12.43. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.92B
Open	$8.79
Day's High	$40.83
Day's Low	$1.21
Previous Close	$8.77
Volume	3.36M
Average Volume	11.53M
P/E Ratio	--
52-Week High	$12.43
52-Week Low	$1.95
Dividend Yield	--
Earnings Date	--

ImmunityBio, Inc. (IBRX) Stock Price Today

ImmunityBio, Inc. (IBRX) is currently trading at $8.50 as of 2026-10-21 14:46:59, down 3.11% ($0.27) from the previous close of $8.77

During today's regular trading session, IBRX has traded between $1.21 and $40.83, with a trading volume of 3.36M shares. The current price is near the lower end of today's range.

ImmunityBio, Inc. (IBRX) 7-Day Stock Price Change

Over the past seven days, ImmunityBio, Inc. (IBRX) moved from $10.12 to $8.50, representing a decline of 16.04% ($1.62).

The stock traded between $8.11 and $10.62 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 18.30 million shares, up versus the previous seven-day period, indicating higher trading activity.

IBRX 52-Week Price Position

Position in Range: 62.5%

52W Low$1.95

52W High$12.43

IBRX is currently trading at $8.50, placing it 62.5% of the way from its 52-week low of $1.95 to its 52-week high of $12.43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ImmunityBio, Inc. (IBRX)?

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

ImmunityBio, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	691
Exchange	NASDAQ
Company Website	https://www.immunitybio.com

How to Buy ImmunityBio, Inc. (IBRX) Stock on MEXC

Eligible investors can buy real shares of ImmunityBio, Inc. (IBRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IBRX and Place Your Order

Open the RealStocks trading page and search for IBRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ImmunityBio, Inc. (IBRX) stock price today?

ImmunityBio, Inc. (IBRX) is currently trading at $ 8.50, down 3.11% ($0.27) from the previous close of $ 8.77. Intraday prices update in real time during regular trading hours.

2.Is IBRX stock going up or down today?

As of 2026-10-21 14:46:59, IBRX is trading at $ 8.50, down 3.11% ($0.27) from its previous close of $ 8.77. The stock has traded between $ 1.21 and $ 40.83 during today’s regular session. Past price movements do not guarantee future results.

3.What is IBRX pre-market price?

As of 2026-10-21 14:46:59, IBRX is trading at $ 8.90 in pre-market trading, up 1.53% ($0.13) from the previous close of $ 8.77. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IBRX after-hours price?

As of 2026-10-21 14:46:59, IBRX is trading at $ 8.79 in after-hours trading, up 0.22% ($0.02) from the regular-session close of $ 8.77. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IBRX stock trading now?

IBRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IBRX sit relative to its 52-week high and low?

Over the past 52 weeks, IBRX has traded between a low of $ 1.95 and a high of $ 12.43. At $ 8.50, the stock is positioned 62.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ImmunityBio, Inc. in?

ImmunityBio, Inc. (IBRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ImmunityBio, Inc.'s market capitalization and where is it listed?

ImmunityBio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.92B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IBRX valued in terms of P/E ratio and EPS?

IBRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.94. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ImmunityBio, Inc. pay a dividend?

ImmunityBio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.